Attached files
| file | filename |
|---|---|
| EX-1.1 - EXHIBIT 1.1 - NATIONAL HEALTH INVESTORS INC | exhibit11.htm |
| 8-K - 8-K - NATIONAL HEALTH INVESTORS INC | a8kitem801atm3-19x2020.htm |
Exhibit 5.1 Exhibit 23.1 | |
 | Hogan Lovells US LLP Columbia Square 555 Thirteenth Street, NW Washington, DC 20004 T +1 202 637 5600 F +1 202 637 5910 www.hoganlovells.com |
March 19, 2020 Board of Directors National Health Investors, Inc. 222 Robert Rose Drive Murfreesboro, TN 37129 Ladies and Gentlemen: We are acting as counsel to National Health Investors, Inc., a Maryland corporation (the “Company”), in connection with the public offering of up to $500,000,000 aggregate gross sales price of the Company’s common stock, $0.01 par value per share (the “Shares”), all of which are to be offered and sold by the Company from time to time pursuant to the terms of the Equity Distribution Agreement, dated March 19, 2020, by and among the Company and each of the persons named on Schedule 1 attached hereto (the “Agreement”). The offering of the Shares by the Company is being made pursuant to a prospectus supplement dated March 19, 2020 and the accompanying base prospectus dated March 19, 2020 (such documents, collectively, the “Prospectus”) that form part of the Company’s effective registration statement on Form S-3 (File No. 333-237278) (the “Registration Statement”). This opinion letter is furnished to you at your request to enable you to fulfill the requirements of Item 601(b)(5) of Regulation S‑K, 17 C.F.R. § 229.601(b)(5), in connection with the Registration Statement. For purposes of this opinion letter, we have examined copies of such agreements, instruments and documents as we have deemed an appropriate basis on which to render the opinion hereinafter expressed. In our examination of the aforesaid documents, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the accuracy and completeness of all documents submitted to us, the authenticity of all original documents, and the conformity to authentic original documents of all documents submitted to us as copies (including pdfs). We also have assumed that the Shares will not be issued in violation of the ownership limit contained in the Company’s Articles of Incorporation, as amended. As to all matters of fact, we have relied on the representations and statements of fact made in the documents so reviewed, and we have not independently established the facts so relied on. This opinion letter is given, and all statements herein are made, in the context of the foregoing. This opinion letter is based as to matters of law solely on the Maryland General Corporation Law, as amended. We express no opinion herein as to any other statutes, rules or regulations. Based upon, subject to and limited by the foregoing, we are of the opinion that following (i) execution and delivery by the Company of the Agreement, (ii) authorization by the Company’s Board of | |
Hogan Lovells US LLP is a limited liability partnership registered in the District of Columbia. “Hogan Lovells” is an international legal practice that includes Hogan Lovells US LLP and Hogan Lovells International LLP, with offices in: Alicante Amsterdam Baltimore Beijing Birmingham Boston Brussels Colorado Springs Denver Dubai Dusseldorf Frankfurt Hamburg Hanoi Ho Chi Minh City Hong Kong Houston Johannesburg London Los Angeles Luxembourg Madrid Mexico City Miami Milan Minneapolis Monterrey Moscow Munich New York Northern Virginia Paris Perth Philadelphia Rome San Francisco São Paulo Shanghai Silicon Valley Singapore Sydney Tokyo Warsaw Washington, D.C. Associated Offices: Budapest Jakarta Riyadh Shanghai FTZ Ulaanbaatar Zagreb. Business Service Centers: Johannesburg Louisville. Legal Services Center: Berlin. For more information see www.hoganlovells.com //DC - 755450/000004 - 14918760 v3 | |
Board of Directors National Health Investors, Inc. | - 2 - | March 19, 2020 |
Directors, or authorization by a duly authorized pricing committee thereof, within the limitations established by resolutions duly adopted by the Company’s Board of Directors and duly authorized pricing committee thereof, of the terms pursuant to which the Shares may be sold pursuant to the Agreement, (iii) authorization by a duly authorized executive officer, designated by the Company’s Board of Directors or the pricing committee to approve placement notices under the Agreement, of the terms of each placement notice issued in a manner consistent with the foregoing and pursuant to which the Shares may be sold pursuant to the Agreement, (iv) issuance of the Shares pursuant to the terms established by the Board of Directors and the pricing committee thereof and the terms of the applicable Agreement and the applicable placement notice, and (v) receipt by the Company of the proceeds for the Shares sold pursuant to the terms of the Agreement and applicable placement notice, the Shares will be validly issued, fully paid, and nonassessable. This opinion letter has been prepared for use in connection with the filing by the Company of a Current Report on Form 8-K on the date hereof relating to the offer and sale of the Shares, which Form 8-K will be incorporated by reference into the Registration Statement and Prospectus, and speaks as of the date hereof. We assume no obligation to advise of any changes in the foregoing subsequent to the delivery of this letter. We hereby consent to the filing of this opinion letter as Exhibit 5.1 to the above-described Form 8-K and to the reference to this firm under the caption “Legal Matters” in the Prospectus. In giving this consent, we do not thereby admit that we are an “expert” within the meaning of the Securities Act of 1933, as amended. Very truly yours, /s/ Hogan Lovells US LLP HOGAN LOVELLS US LLP | ||
//DC - 755450/000004 - 14918760 v3 | ||
Schedule 1 | ||
KeyBanc Capital Markets, Inc. 127 Public Square, 4th Floor Cleveland, OH 44114 BMO Capital Markets Corp. 3 Times Square, 25th Floor New York, NY 10036 Capital One Securities, Inc. 299 Park Avenue, 29th Floor New York, NY 10171 Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 Stifel, Nicolaus & Company, Incorporated 501 N Broadway, 9th Floor St. Louis, Missouri 63102 Wells Fargo Securities LLC 550 South Tryon Street Charlotte, NC 28202 J.P. Morgan Securities LLC 383 Madison Avenue New York, NY 10017 BofA Securities, Inc. One Bryant Park New York, NY 10036 | ||
//DC - 755450/000004 - 14918760 v3 | ||